Evidence map›Paper›PMID 25268351›Full record

ArticlePloS one2014

Diagnostic value of a Rec-ELISA using Toxoplasma gondii recombinant SporoSAG, BAG1, and GRA1 proteins in murine models infected orally with tissue cysts and oocysts.

Mert Döşkaya, Ayşe Caner, Hüseyin Can, Sultan Gülçe İz, Yaprak Gedik, Aysu Değirmenci Döşkaya, Mina Kalantari-Dehaghi, Yüksel Gürüz

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.9field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Limited value of current and newFrontiers in parasitology · 2023
    Article
  9. Application ofFrontiers in cellular and infection microbiology · 2022
    Article
  10. Identification of Oocyst-DrivenMicroorganisms · 2021
    Review
  11. Article
  12. Article
  13. Article
  14. Key Limitations and New Insights Into theFrontiers in cellular and infection microbiology · 2020
    Review
  15. Review on the Current Trends of Toxoplasmosis Serodiagnosis in Humans.Frontiers in cellular and infection microbiology · 2020
    Review
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Mert DöşkayaDepartment of Parasitology, Ege University Medical School, Bornova/İzmir, Turkey.
Ayşe CanerDepartment of Parasitology, Ege University Medical School, Bornova/İzmir, Turkey.
Hüseyin CanDepartment of Parasitology, Ege University Medical School, Bornova/İzmir, Turkey; Department of Molecular Biology, Ege University Faculty of Sciences, Bornova/İzmir, Turkey.
Sultan Gülçe İzDepartment of Bioengineering, Ege University Faculty of Engineering, Bornova/İzmir, Turkey.
Yaprak GedikDepartment of Parasitology, Ege University Medical School, Bornova/İzmir, Turkey; Department of Bioengineering, Ege University Faculty of Engineering, Bornova/İzmir, Turkey.
Aysu Değirmenci DöşkayaDepartment of Parasitology, Ege University Medical School, Bornova/İzmir, Turkey.
Mina Kalantari-DehaghiDepartment of Dermatology, University of California Irvine, Irvine, California, United States of America.
Yüksel GürüzDepartment of Parasitology, Ege University Medical School, Bornova/İzmir, Turkey.
Ege University · TRUniversity of California, Irvine · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Toxoplasma gondii causes congenital toxoplasmosis in newborns resulting with fetal anomalies. Determining the initiation time of infection is very important for pregnant women and current serological assays have drawbacks in distinguishing the recently acute toxoplasmosis. Diagnosis of recently acute infection may be improved by using stage specific antigens in serological assays. In the present study, the diagnostic value of sporozoite specific SporoSAG, bradyzoite specific BAG1 proteins and GRA1 protein expressed by all forms of the parasite have been evaluated ELISA using sera systematically collected from mice administered orally with tissue cyst and oocysts. The anti-SporoSAG IgM antibodies in sera obtained from mice infected with oocysts peaked significantly at days 1, 10, and 15 (P<0.01). The anti-BAG1 IgM antibodies in sera obtained from mice infected with tissue cysts peaked significantly at days 15, 40, and 120 (P<0.05). The anti-GRA1 IgM antibodies in sera obtained from mice infected with oocysts peaked significantly at days 2, 10, and 40 (P<0.01). The anti-GRA1 IgM antibodies in sera obtained from mice infected with tissue cysts peaked significantly only at day 40 (P<0.05). The anti-SporoSAG, anti-BAG1, and anti-GRA1 IgG titers of mice showed significant increases at day 40 (P<0.05) and decrement started for only anti-GRA1 IgG at day 120. The presence of anti-SporoSAG IgM and IgG antibodies can be interpreted as recently acute infection between days 10-40 because IgM decreases at day 40. Similarly, presence of anti-BAG1 IgM and absence of IgG can be evaluated as a recently acute infection that occurred 40 days before because IgG peaks at day 40. A peak in anti-GRA1 antibody level at first testing and reduction in consecutive sample can be considered as an infection approximately around day 40 or prior. Overall, recombinant SporoSAG, BAG1 and GRA1 proteins can be accepted as valuable diagnostic markers of recently acute toxoplasmosis.

Indexed as

Acute DiseaseAdministration, OralAnimalsAntibodies, ProtozoanAntigens, ProtozoanEnzyme-Linked Immunosorbent AssayFemaleGene ExpressionHeat-Shock ProteinsImmunoglobulin GImmunoglobulin MMiceOocystsProtozoan ProteinsRecombinant ProteinsToxoplasmaAntibodies, ProtozoanAntigens, ProtozoanBAG1 protein, ToxoplasmaGRA1 antigenHeat-Shock ProteinsImmunoglobulin GImmunoglobulin MProtozoan ProteinsRecombinant ProteinsSAG1 antigen, Toxoplasma

Identifiers

PMID25268351
PMCPMC4182662
OpenAlexW2016644423

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.